Last reviewed · How we verify
Matching Placebo to Ustekinumab — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Matching Placebo to Ustekinumab (Matching Placebo to Ustekinumab) — Janssen Research & Development, LLC. This is a placebo formulation designed to match the appearance and administration route of ustekinumab for blinded clinical trial comparison.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Matching Placebo to Ustekinumab TARGET | Matching Placebo to Ustekinumab | Janssen Research & Development, LLC | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Matching Placebo to Ustekinumab CI watch — RSS
- Matching Placebo to Ustekinumab CI watch — Atom
- Matching Placebo to Ustekinumab CI watch — JSON
- Matching Placebo to Ustekinumab alone — RSS
Cite this brief
Drug Landscape (2026). Matching Placebo to Ustekinumab — Competitive Intelligence Brief. https://druglandscape.com/ci/matching-placebo-to-ustekinumab. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab